Literature DB >> 22767658

Essential thrombocythemia in a young man treated for myocardial infarction.

S Pande1, R Joshi, R Pande.   

Abstract

Essential thrombocythemia (ET) is a chronic myeloproliferative neoplasm which can cause thrombohaemorrhagic complications usually involving microvasculature. Medium-sized arterial thrombosis has been reported, but coronary occlusion usually occurs with additional risk factors, for example, smoking, hyperlipidaemia and so on. We present a case of acute myocardial infarction (AMI) in a young man (29 years) with ET but without any coronary artery associated risk factors. He was successfully treated for his AMI and ET with cytoreductive treatment and has recovered well. Due to automated platelet counting, ET is being increasingly identified; early detection can prevent long-term complications, and patients can have normal life span.

Entities:  

Mesh:

Year:  2010        PMID: 22767658      PMCID: PMC3029839          DOI: 10.1136/bcr.09.2009.2234

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  When and how to treat essential thrombocythemia.

Authors:  Tiziano Barbui; Guido Finazzi
Journal:  N Engl J Med       Date:  2005-07-07       Impact factor: 91.245

Review 2.  Advances in understanding and management of myeloproliferative neoplasms.

Authors:  Alessandro M Vannucchi; Paola Guglielmelli; Ayalew Tefferi
Journal:  CA Cancer J Clin       Date:  2009-04-15       Impact factor: 508.702

Review 3.  Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia.

Authors:  S Murphy
Journal:  Semin Hematol       Date:  1999-01       Impact factor: 3.851

4.  Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.

Authors:  Claire N Harrison; Peter J Campbell; Georgina Buck; Keith Wheatley; Clare L East; David Bareford; Bridget S Wilkins; Jon D van der Walt; John T Reilly; Andrew P Grigg; Paul Revell; Barrie E Woodcock; Anthony R Green
Journal:  N Engl J Med       Date:  2005-07-07       Impact factor: 91.245

5.  Acute myocardial infarction with essential thrombocythemia in a young man.

Authors:  R A Pick; M U Glover; J J Nanfro; W F Dubbs; J A Gibbons; W V Vieweg
Journal:  Am Heart J       Date:  1983-08       Impact factor: 4.749

6.  Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995.

Authors:  R A Mesa; M N Silverstein; S J Jacobsen; P C Wollan; A Tefferi
Journal:  Am J Hematol       Date:  1999-05       Impact factor: 10.047

Review 7.  Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment.

Authors:  S Murphy; P Peterson; H Iland; J Laszlo
Journal:  Semin Hematol       Date:  1997-01       Impact factor: 3.851

8.  Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

Authors:  Ayalew Tefferi; Juergen Thiele; Attilio Orazi; Hans Michael Kvasnicka; Tiziano Barbui; Curtis A Hanson; Giovanni Barosi; Srdan Verstovsek; Gunnar Birgegard; Ruben Mesa; John T Reilly; Heinz Gisslinger; Alessandro M Vannucchi; Francisco Cervantes; Guido Finazzi; Ronald Hoffman; D Gary Gilliland; Clara D Bloomfield; James W Vardiman
Journal:  Blood       Date:  2007-05-08       Impact factor: 22.113

  8 in total
  3 in total

1.  Acute ST-segment elevation myocardial infarction in a young patient with essential thrombocythemia: a case with long-term follow-up report.

Authors:  Tariq Bhat; Mohammed Ahmed; Hassan Baydoun; Zahraa Ghandour; Alina Bhat; Donald McCord
Journal:  J Blood Med       Date:  2014-07-23

2.  Myocardial infarction as a thrombotic complication of essential thrombocythemia and polycythemia vera.

Authors:  Éva Pósfai; Imelda Marton; Zita Borbényi; Attila Nemes
Journal:  Anatol J Cardiol       Date:  2016-02-04       Impact factor: 1.596

3.  What cardiologists should know about essential thrombocythemia and acute myocardial infarction: report of two cases and advanced heart failure therapies considerations.

Authors:  Marie-Camille Soucy-Giguère; Pierre Yves Turgeon; Mario Sénéchal
Journal:  Int Med Case Rep J       Date:  2019-08-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.